Molecular Partners AG annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
Molecular Partners AG Stock-Based Compensation Growth & History (MOLN)
Molecular Partners AG's stock-based compensation was CHF4.3M for fiscal 2025.
View full Molecular Partners AG company overviewMolecular Partners AG annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF4.3M | CHF172,000 | +4.19% |
| 2024 | 2024-12-31 | CHF4.1M | −CHF1.1M | −21.16% |
| 2023 | 2023-12-31 | CHF5.2M | CHF119,000 | +2.34% |
| 2022 | 2022-12-31 | CHF5.1M | CHF1.0M | +24.55% |
| 2021 | 2021-12-31 | CHF4.1M | CHF1.2M | +39.32% |
| 2020 | 2020-12-31 | CHF2.9M | CHF494,000 | +20.26% |
| 2019 | 2019-12-31 | CHF2.4M | — | — |
Molecular Partners AG quarterly stock-based compensation
Q2.22
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | CHF907,000 | −CHF321,000 | −26.14% |
| Q1 2026 | 2026-03-31 | CHF936,000 | −CHF206,000 | −18.04% |
| Q4 2025 | 2025-12-31 | CHF973,000 | — | — |
| Q3 2025 | 2025-09-30 | CHF1.1M | — | — |
| Q2 2025 | 2025-06-30 | CHF1.2M | CHF99,000 | +8.77% |
| Q1 2025 | 2025-03-31 | CHF1.1M | — | — |
| Q2 2024 | 2024-06-30 | CHF1.1M | −CHF183,000 | −13.95% |
| Q2 2023 | 2023-06-30 | CHF1.3M | −CHF210,000 | −13.80% |
| Q2 2022 | 2022-06-30 | CHF1.5M | — | — |
Molecular Partners AG stock-based compensation trends
Over the last five fiscal years, Molecular Partners AG's stock-based compensation increased from CHF2.9M to CHF4.3M, a change of CHF1.3M. The latest reported quarter, Q2 2026, shows CHF907,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Molecular Partners AG source filings ↗